| EPE421 | Responding to the COVID-19 pandemic: HIV continuing professional development virtual seminars for healthcare workers in Ukraine | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPB086 | Retention in care in pregnant HIV positive Kaposi Sarcoma (KS) patients seen at a tertiary hospital in Harare, Zimbabwe: a case control study | E-poster | Malignancies (AIDS and non-AIDS) |
| EPC321 | Retention of clients on daily oral HIV pre-exposure prophylaxis in Vietnam | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC448 | Retention on treatment and mortality of methadone maintenance therapy patients before and after take-home dosing policy change during COVID-19 pandemic in Ukraine | E-poster | Effects of the COVID-19 on HIV epidemiology and prevention |
| EPD138 | Retention strategies in the first Pre-Exposure Prophylaxis (PrEP) observational cohort among those on community supervision in the South: lessons learned during the SARS-COV-2 pandemic | E-poster | Prisoners and other incarcerated people |
| EPC149 | Rethinking resources for HIV prevention: the need for couples-based testing in Zambia | E-poster | Modelling the impact of prevention strategies on the HIV epidemic |
| EPF041 | Rethinking the development agenda: Advocating for the full inclusion and participation of men who have sex with men and transgender people in the South African health care system | E-poster | Sexual- and/or gender-based inequalities, inequities and violence |
| EPA043 | Retinoic acid boosts HIV-1 replication in Monocyte-Derived Macrophages | E-poster | Host cellular factors and viral mechanisms of HIV/SIV persistence and latency |
| EPC255 | Return to opioid use following release from incarceration: Findings from a prison-based methadone maintenance treatment program for men living with HIV and opioid use disorder in Malaysia | E-poster | HIV prevention services for key populations |
| EPB077 | Reversibility of neuropsychiatric adverse events after switching to darunavir/cobicistat or doravirine in men on INSTI based regimen | E-poster | Mental health (including depression and psychiatric manifestations) and HIV |